Skip Navigation


QJM Advance Access originally published online on May 6, 2005
QJM 2005 98(6):435-441; doi:10.1093/qjmed/hci069
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
98/6/435    most recent
hci069v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gaya, D.R.
Right arrow Articles by Mackenzie, J.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaya, D.R.
Right arrow Articles by Mackenzie, J.F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Faecal calprotectin in the assessment of Crohn's disease activity

D.R. Gaya1, T.D.B. Lyon2, A. Duncan2, J.B. Neilly3, S. Han3, J. Howell3, C. Liddell1, A.J. Stanley1, A.J. Morris1 and J.F. Mackenzie1

From the Departments of 1Gastroenterology, 2Biochemistry and 3Nuclear Medicine, Glasgow Royal Infirmary, Glasgow, UK

Address correspondence to Dr D.R. Gaya, Dept of Gastroenterology, Glasgow Royal Infirmary, 84 Castle Street, Glasgow G4 0SF. e-mail: danielgaya{at}aol.com

Received 6 September 2004 and in revised form 14 January 2005

Background: Clinical and laboratory assessment of activity in Crohn's disease (CD) correlate poorly with endoscopic findings. Calprotectin is a calcium-binding protein abundant in neutrophil cytosol, and extremely stable in faeces. Faecal calprotectin (FC) is an excellent surrogate marker of neutrophil influx into the bowel lumen.

Aim: To assess whether FC concentration from a spot stool sample reliably detects active inflammation in patients with CD.

Design: Cross-sectional comparative study.

Methods: Subjects had a previously confirmed diagnosis of CD and were suspected on clinical grounds to be in the midst of a relapse. Thirty-five entered the study; they underwent radiolabelled white cell scanning (WCS) and had a stool sample collected for calprotectin measurement on the same day. A Crohn's disease activity index (CDAI) was also calculated for each. The WCS scans were scored at six standard sites to give a mean total, ‘extent‘, ‘severity’ and ‘combined extent and severity’ scores.

Results: FC was significantly and positively correlated with mean total (r = 0.73, p<0.001), ‘extent’ (r = 0.71, p<0.001), ‘severity’ (r = 0.64, p<0.001) and combined ‘extent and severity’ WCS scores (r = 0.71, p<0.001). A cut-off of faecal calprotectin >100 µg/g gave a sensitivity of 80%, specificity of 67%, positive predictive value of 87% and a negative predictive value of 64% in identifying those with and without any inflammation on WCS. There was, however, no significant correlation between CDAI and mean total WCS score (r = 0.21, p = 0.24), nor between CDAI and FC (r = 0.33, p = 0.06).

Discussion: While the CDAI does not accurately reflect inflammatory activity in CD, a one-off FC reliably detects the presence or absence of intestinal inflammation in adult patients with CD, compared to WCS.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.